Literature DB >> 1717718

Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.

R C Craven1, R P Bennett, J W Wills.   

Abstract

The retroviruses of the avian sarcoma-leukosis virus group synthesize their viral protease (PR) in two precursor forms--as a carboxy-terminal domain of the Gag precursor and as an embedded domain within the Gag-Pol precursor. We have shown previously that the Gag-derived PR is fully capable of processing the Gag precursor in the absence of the embedded PR (R.P. Bennett, S. Rhee, R.C. Craven, E. Hunter, and J.W. Wills, J. Virol. 65:272-280, 1991). In this study, we examined the question of whether or not the PR domain of Gag-Pol has an essential role in the maturation of the Pol proteins. The Gag-Pol precursor was expressed in the absence of Gag by use of a simian virus 40-based vector in which the gag and pol reading frames were fused. The fusion protein accumulated to high levels in transfected cells without being released into the medium but could be rescued into particles by coexpression of the Gag protein from a second vector. The resulting particles contained mature Gag and Pol proteins and active reverse transcriptase (RT). Using this complementation system, the effects of PR defects in the Gag and/or Gag-Pol proteins on the activation of RT were examined. The results showed that the presence of a functional PR on the Gag precursor, but not on Gag-Pol, was required for full activation of RT. The embedded PR of Gag-Pol was unable to carry out any detectable processing of the Gag precursor and was able to activate RT to only a low level in the absence of a functional Gag PR domain. Finally, some point mutations in the Gag-Pol PR domain inhibited activation of RT in trans by a wild-type PR, suggesting that the correct conformation of the PR domain in Gag-Pol is prerequisite for activation of RT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717718      PMCID: PMC250313     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Retroviral reverse transcriptase: synthesis, structure, and function.

Authors:  S P Goff
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

2.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Incorporation of chimeric gag protein into retroviral particles.

Authors:  R A Weldon; C R Erdie; M G Oliver; J W Wills
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

Review 4.  Translational suppression in gene expression in retroviruses and retrotransposons.

Authors:  T Jacks
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

5.  Myristylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells.

Authors:  C R Erdie; J W Wills
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

6.  Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Purification and properties of a fifth major viral gag protein from avian sarcoma and leukemia viruses.

Authors:  R B Pepinsky; V M Vogt
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

9.  Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyproteins.

Authors:  R B Pepinsky; R J Mattaliano; V M Vogt
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

10.  Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution.

Authors:  M Jaskólski; M Miller; J K Rao; J Leis; A Wlodawer
Journal:  Biochemistry       Date:  1990-06-26       Impact factor: 3.162

View more
  33 in total

1.  Insertion of capsid proteins from nonenveloped viruses into the retroviral budding pathway.

Authors:  N K Krishna; J W Wills
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Transposition of a Ty3 GAG3-POL3 fusion mutant is limited by availability of capsid protein.

Authors:  J Kirchner; S B Sandmeyer; D B Forrest
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Complementation studies with Rous sarcoma virus gag and gag-pol polyprotein mutants.

Authors:  S Oertle; N Bowles; P F Spahr
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.

Authors:  H Burstein; D Bizub; M Kotler; G Schatz; V M Vogt; A M Skalka
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.

Authors:  T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Identification of retroviral late domains as determinants of particle size.

Authors:  L Garnier; L J Parent; B Rovinski; S X Cao; J W Wills
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Retrotransposition of nonviral RNAs in an avian packaging cell line.

Authors:  R Lum; M L Linial
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Conditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.

Authors:  R P Bennett; J W Wills
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.